Moffitt Cancer Center and Cryoport Announce Strategic Collaboration [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
TAMPA, Fla. and NASHVILLE, Tenn. Jan. 14, 2025 /PRNewswire/ -- Moffitt Cancer Center , a leading National Cancer Institute-designated comprehensive cancer center, through its wholly owned subsidiary Speros FL , a 775-acre global innovation life sciences campus, and Cryoport, Inc. (NASDAQ: CYRX), a global leader in supply chain solutions for the life sciences industry, today announced a strategic collaboration that will provide CRYOGENE 's state-of-the-art biorepository services to Speros in Pasco County, Florida . Cryoport's CRYOGENE business unit is a leading biorepository for the life sciences industry that is focused on the secure storage of biological specimens and associated services. Cryoport logo 2024 "Our goal is to make Speros the cell and gene therapy capital of the world," said Patrick Hwu , M.D. , president and CEO of Moffitt. "With the addition of CRYOGENE, we will accelerate discovery by igniting collaborations and partnerships across disciplines to bring new therap
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- How Recent Developments Are Rewriting the Story for Cryoport and Its Valuation Outlook [Yahoo! Finance]Yahoo! Finance
- Cryoport: Picks And Shovels For The Gene Therapy Boom [Seeking Alpha]Seeking Alpha
- CryoPort (NASDAQ:CYRX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- How the Story Behind Cryoport Is Evolving After Recent Analyst and Market Developments [Yahoo! Finance]Yahoo! Finance
- CryoPort (NASDAQ:CYRX) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
CYRX
Earnings
- 11/4/25 - Beat
CYRX
Sec Filings
- 12/12/25 - Form 4
- 12/10/25 - Form 144
- 11/12/25 - Form SCHEDULE
- CYRX's page on the SEC website